May 11 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 14.81 13.18 16.80
(+12.4 pct) (-4.4 pct) (+13.4 pct)
Operating 1.53 282 mln 1.80
(+439.3 pct) (-77.4 pct) (+18.0 pct)
Recurring 1.54 244 mln 1.77
(+529.4 pct) (-79.8 pct) (+15.1 pct)
Net
Net 982 mln 44 mln 1.17
(-95.1 pct) (+19.1 pct)
EPS 249.74 yen 11.40 yen 297.43 yen
Ann Div 20.00 yen 20.00 yen 20.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 20.00 yen 20.00 yen 20.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T
((Tokyo Headline News Desk +813 6441 1812))